Fitbit, Inc. has received US Food and Drug Administration clearance and the European Union's CE mark for its electrocardiogram app to assess users’ heart rhythms for atrial fibrillation (AFib) with a launch planned for October.
“Early detection of AFib is critical, and I’m incredibly excited that we are making these innovations accessible to people around the world to help them improve their heart health, prevent more serious conditions and potentially save lives,” said